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ABSTRACT hCT(9-32) is a human calcitonin (hCT)-derived cell-penetrating peptide that has been shown to translocate the
plasma membrane of mammalian cells. It has been suggested as a cellular carrier for drugs, green ﬂuorescent protein, and
plasmid DNA. Because of its temperature-dependent cellular translocation resulting in punctuated cytoplasmatic distribution, its
uptake is likely to follow an endocytic pathway. To gain insight into the molecular orientation of hCT(9-32) when interacting with
lipid models, and to learn more about its mode of action, various biophysical techniques from liposome partitioning to high-
resolution NMR spectroscopy were utilized. Moreover, to establish the role of individual residues for the topology of its asso-
ciation with the lipid membrane, two mutants of hCT(9-32), i.e., W30-hCT(9-32) and A23-hCT(9-32), were also investigated.
Although unstructured in aqueous solution, hCT(9-32) adopted two short helical stretches when bound to dodecylphosphocho-
line micelles, extending from Thr10 to Asn17 and from Gln24 to Val29. A23-hCT(9-32), in which the helix-breaking Pro23 was
replaced by Ala, displayed a continuous a-helix extending from residue 12 to 26. Probing with the spin label 5-doxylstearate
revealed that association with dodecylphosphocholine micelles was such that the helix engaged in parallel orientation to the
micelle surface. Moreover, the Gly to Trp exchange in W30-hCT(9-32) resulted in a more stable anchoring of the C-terminal
segment close to the interface, as reﬂected by a twofold increase in the partition coefﬁcient in liposomes. Interestingly, tighter
binding to model membranes was associated with an increase in the in vitro uptake in human cervix epithelial andenocarcinoma
cell line cells. Liposome leakage studies excluded pore formation, and the punctuated ﬂuorescence pattern of internalized pep-
tide indicated vesicular localization and, in conclusion, strongly suggested an endocytic pathway of translocation.
INTRODUCTION
Appropriate delivery of drugs to their sites of action is com-
plicated by a number of factors. A prominent one is poor
translocation through the cellular membrane that represents
a major barrier for peptide, protein, and nucleic acid bio-
pharmaceuticals. To aid in this process, several classes and/
or prototypes of cell-penetrating peptides (CPPs) have been
introduced during the past decade. Most of them consist of
short, often oligocationic peptide sequences, which may be
covalently linked to the compound of interest. Recently also,
peptides capable of forming noncovalent complexes with the
cargo have been developed (1–3).
The ability of CPPs to translocate the membrane when
covalently linked or noncovalently complexed with a cargo
renders them of broad interest in cell biology, biotechnology,
and drug delivery. In fact, CPPs have been suggested as vec-
tors for the cytoplasmic and nuclear delivery of hydrophilic
biomolecules and drugs, both in vivo and in vitro (4–6).
Initially, the mechanism of entry was ﬁrmly believed not to
be mediated by receptors or transporters (4,5), suggesting a
passive, nonendocytic transfer. However, it was soon recog-
nized that cell ﬁxation could cause artifactual uptake
phenomena. Hence, the hypothesis of an energy-independent,
direct transport of CPPs through biomembranes, as postu-
lated in earlier CPP studies (7–9), had to give way to con-
cepts involving endocytosis (10–14).
Much attention has been concentrated on the ﬁrst step
of CPP uptake, i.e., the interaction with the surface of the
membrane leading to an enrichment and/or perturbation of
the phospholipid bilayer, which may subsequently trigger
endocytic uptake (14,15). In fact, in the few studies available
in the literature that combine cell biological and biophysical
approaches, good correlations between membrane afﬁnity
and uptake efﬁciency have been observed (16,17).
In this study, we determined the secondary structure
and micellar localization of a human calcitonin-derived CPP,
hCT (9-32), in contact with a membrane-mimicking envi-
ronment, namely dodecylphosphocholine (DPC) micelles.
Based on these results, we identiﬁed amino acids critical for
membrane binding. Amino acids were replaced to enhance
the afﬁnity of the modiﬁed peptides toward biomembranes.
The propensity of the modiﬁed peptides to bind to phos-
pholipid bilayers was ﬁrst assessed in liposome/buffer equi-
librium dialysis experiments and compared to data for the
wild-type peptide. A more detailed investigation of the posi-
tioning of the CPPs in DPC micelles was then performed in
a NMR study utilizing a paramagnetic spin label. Finally the
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membrane translocating potential was investigated in a cell
culture model.
Human calcitonin (hCT) is a peptide hormone that is ap-
proved for the treatment of established osteoporosis (18).
N-terminally truncated derivatives of hCT, lacking hormonal
activity, represent a novel class of weakly cationic CPPs and
have been systematically investigated by Tre´hin et al. (19). It
has been shown that sequences from hCT(9-32) to hCT(18-
32) could—at least to some extent—translocate the plasma
membrane of a fully organized epithelial model, fully dif-
ferentiated Madin-Darby canine kidney cell line (MDCK)
monolayers, resulting in a sectoral, vesicular cytoplasmic
distribution of the peptide. The uptake process was tem-
perature, time, and concentration dependent, indicating that
translocation may follow an endocytic pathway. Among the
investigated derivatives hCT(9-32) was the most efﬁcient
one in this respect, and its single, positively charged lysine
in position 18 turned out to be essential for uptake (19).
Furthermore, uptake was found to be cell-line speciﬁc with a
punctuated, cytoplasmic pattern in MDCK cells and para-
cellular accumulation in Calu-3 cell monolayers. Remarkably,
hCT-derived peptides did not show signiﬁcant permeation
across epithelial models (20). This is owing to their efﬁcient
metabolic cleavage when in contact with epithelial cells (21).
In a previous 1HNMR study, full-length hCTwas structurally
characterized in sodiumdodecylsulfate (SDS)micelles and found
to form an amphipathic a-helix encompassing residues 9–6
(22). A recent solid-state NMR study showed that hCT(9-32)
interacts preferably with the headgroups of a bilayer formed by a
mixture of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC),
1-palmitoyl-2-oleoyl-phosphatidylethanolamine (POPE), and
1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) (in a 5:3:2
molar ratio) rather than with the hydrophobic core of the
phospholipids (23). This work represents the ﬁrst solution
state NMR study to determine the secondary structure of
hCT(9-32) and its orientation relative to the surface of the
lipid micelle. As a result we observed formation of two short
a-helical stretches in DPC micelles, which were interrupted
by the Pro in position 23 for hCT(9-32). The wild-type se-
quence only moderately interacted with the interface of the
micelles, whereas A23-hCT(9-32) revealed higher afﬁnity
for membrane binding due to its extended a-helix. Moreover,
insertion of an additional, hydrophobic membrane anchor in
W30-hCT(9-32) caused an even increased interaction with
the micelle along the entire sequence. The enhanced afﬁnity
for membrane binding was reﬂected by a signiﬁcantly higher
uptake of W30-hCT(9-32) in human cervix epithelial an-
denocarcinoma cell line (HeLa) cells when compared to
hCT(9-32).
MATERIALS AND METHODS
Deuterated docecylphosphatidylcholine (DPC-d38, 99%-d) and dideuterium
oxide (D2O) were ordered from Cambridge Isotope Laboratories (Andover,
MA). POPC of the best quality available was purchased from Avanti Polar
Lipids (Alabaster, AL) and used without further puriﬁcation. Melittin
(purity .93%), 5-doxylstearic acid was bought from Aldrich (Buchs,
Switzerland). The peptides used for uptake studies were N-terminally la-
beled with 5-carboxyﬂuoresein and synthesized by NMI Peptides (Reutlingen,
Germany); their identity and purity (.95%) were controlled by mass
spectral and high performance liquid chromatography (HPLC) analysis.
Triﬂuoroacetic acid (TFA), manganese chloride (both analytical grade),
calcein, acetic acid (reagent grade), phosphate-buffered saline (PBS) for
buffer preparation, and Trypan blue solution in 0.81% sodium chloride and
0.06% potassium phosphate were purchased from Fluka (Buchs, Switzer-
land). hCT was kindly provided by Novartis Pharma AG (Basel, Switzer-
land).
Synthesis and puriﬁcation of
hCT-derived peptides
The sequences of the investigated hCT-derived peptides are given in Table 1.
The peptides were synthesized by automated multiple solid phase peptide
synthesis employing the Fmoc/tert. butyl strategy (24). After cleavage from
the resin with TFA, the lyophilized peptides were puriﬁed by preparative
reversed phase (RP) HPLC. The expected molecular weight was veriﬁed by
matrix-assisted laser desorption/ionization-time of ﬂight (MALDI-TOF)
mass spectrometry (Voyager Perseptive II, Weiterstadt, Germany), and
retention times were determined using a LiChrospher 100 RP-18 column
with a linear gradient mobile phase starting at 90% solvent A (water/TFA,
99.9:0.1) (v/v) and 10% solvent B (acetonitrile/TFA, 99.92:0.08) (v/v) to
60% solvent B over 30 min at a ﬂow rate of 1 mL/min: A23-hCT(9-32):
masscalc. 2583.8 Da, massexp. 2584.90 Da, RP-HPLC retention time 19.41
min; W30-hCT(9-32): masscalc. 2739.0 Da, massexp. 2740.72 Da, HPLC
retention time 20.75 min.
Preparation of LUVs
Large unilamellar vesicles (LUVs) were prepared by dissolving the
phospholipids in chloroform to ensure complete solution and mixing of
the components. The lipids were dried at 37C in a rotary evaporator to yield
a thin ﬁlm and then kept under high vacuum over night. The dry ﬁlm then
was redispersed in the buffer and the resulting multilamellar vesicle (MLV)
dispersion was subjected to ﬁve freeze-thaw cycles. LUVs were obtained
by extruding four times through 0.4 mm and eight times through 0.1 mm
Nuclepore polycarbonate membranes. Lipid concentration was determined
TABLE 1 Abbreviations, amino acid sequences, and molecular weights of the peptides studied
in this work; amino acid substitutions are underlined
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by an enzymatic colorimetric test for phospholipids (MPR 2) obtained from
Roche Diagnostics (Mannheim, Germany), and the LUV size was checked
by photon correlation spectroscopy on a Zetasizer 3000 HSA (Malvern, UK).
Liposome-buffer partitioning experiments
Liposome-buffer partitioning experiments were performed by equilibrium
dialysis through a cellulose dialysis membrane, molecular weight cutoff
10,000 Da, at 37C during 7 h using a protocol described by Pauletti et al. in
more detail (25). Lipid concentrations of 4 mM and peptide concentra-
tions of 20 mM were used. For HPLC analysis, liposomes were dissolved
in a threefold excess of methanol and analyzed according to the method
described by Buck and Maxl (26). In all measurements, values at 7 h were
used for calculation of apparent partition coefﬁcients (D) according to




where CP(b) is the concentration of peptide bound to liposomes, CP(f) the
concentration of free peptide, and CL is the concentration of lipid molecules.
CP(b) was calculated by subtracting the peptide concentration in the buffer
compartment from the peptide concentration in the liposome compartment.
Preparation of calcein-containing LUVs
LUVs were prepared by dissolving the phospholipids in chloroform as
described above. The lipids were dried at 37C in a rotary evaporator to yield
a thin ﬁlm and then kept under high vacuum over night. The dry ﬁlm then
was redispersed in buffer (20 mM calcein, in PBS pH 7.4, containing 1 mM
EDTA for complexing of Ca21/Mg21, which could affect calcein ﬂuo-
rescence), and the resulting MLV solution was treated by ﬁve freeze-thaw
cycles. LUVs were then obtained by extruding four times through 0.4 mm
and eight times through 0.1 mm Nuclepore polycarbonate membranes (28).
A plastic syringe mounted in a centrifugation tube was ﬁlled with hydrated
Sephadex G-50 gel. Untrapped dye was removed by the minicolumn
centrifugation method (29) by spinning at 200 g for 3 min.
Dye efﬂux measurements
A total of 50 mL of a 400 mM LUV suspension was injected into 96 well
plates (Nunc, Wiesbaden, Germany) containing 50 mL of peptide solutions
of different concentration. Calcein leakage from vesicles was monitored
ﬂuorimetrically by measuring the decrease in self-quenching (excitation at
462 nm, emission at 525 nm) after 60 min at room temperature on a Varian
Cary Eclipse spectroﬂuorometer (Mulgrave, Australia). The buffer blank
was subtracted form all values, and the ﬂuorescence intensity corresponding
to 100% leakage was determined after the addition of Triton X-100 (30).
Results were displayed as percentage of maximum leakage.
NMR spectroscopy
Accelerated exchange of amide protons in smaller peptides limits the use
of this technique to values between ;3 and 5, whereas the apparent pH in
the water-micelle interface is lightly shifted, allowing us to record data at
higher pH. Moreover, line widths of micelle-associated peptides are larger
due to the increased time for rotational diffusion (39). Therefore, experi-
mental conditions were adjusted to meet the speciﬁc requirements in these
two environments. Accordingly, all NMR experiments utilized 2 mM solu-
tions of peptides at pH 5.6 in the presence of 300 mM d38-dodecylpho-
phocholine (resulting in;1 peptide associated to every third micelle (31)) in
90% H2O/D2O, and spectra were recorded at 310 K on a Bruker (Karlsruhe,
Germany) DRX-500 spectrometer. In our investigations of the peptides in
the absence of detergent, data were recorded at pH 4.1 and at 300 K.
Sequence-speciﬁc resonance assignments were performed based on two-
dimensional data from 12 ms and 40 ms clean total correlation NMR
spectroscopy (TOCSY) experiments (32) and from a 120 ms nuclear
Overhauser effect NMR spectroscopy (NOESY) experiment (33). Other-
wise, we largely followed protocols developed by Wu¨thrich and co-workers
for assignment purposes (34). Upper limits derived from the NOESY data
were used as restraints for torsion angle molecular dynamics runs
performed within the program DYANA (35), using its standard simulated
annealing protocol.
To determine the micelle-binding interface, we measured the decrease in
peak intensity in the 12 ms TOCSY spectra after addition of the micelle-
integrating spin label 5-doxylstearate, which was previously shown to be
positioned in vicinity to the phospholipids’ headgroups (36,37). We com-
puted two subsets of values corresponding to integrals from only the HN,Ha
crosspeaks in the ﬁngerprint region and from the average from all peaks
corresponding to one amino acid and analyzed their intensity ratio in the
presence and absence of the spin labels as determined in the program
XEASY (38). Otherwise we used methodology described by us in more
detail in Bader et al. (39,40).
Cell culture
HeLa cells, a human cervix epithelial adenocarcinoma-derived cell line,
used throughout this study, were obtained from American Type Culture
Collection ATCC (Rockville, MD). Cells were used within ﬁve passages.
Cell culture was maintained under standard cell culture conditions in hu-
midiﬁed 5% CO2. Cells were cultured as exponentially growing subcon-
ﬂuent monolayers and maintained in Dulbecco’s modiﬁed Eagles medium
with GlutaMAX, sodium pyruvate, 4500 mg/L glucose, supplemented with
10% heat-inactivated fetal calf serum and penicillin/streptomycin (100 units/
mL and 100 mg/mL, respectively).
Confocal laser scanning microscopy—uptake
studies in living cells
To assess the cellular localization of the investigated ﬂuorescent labeled
CPPs, we performed confocal laser scanning microscopy (CLSM). Expo-
nentially growing HeLa cells were seeded onto eight well Lab-Tek
chambered coverglasses at a density of 35,000 cells/cm2. Cells were used
1 day after seeding. For uptake experiments, cells were incubated for 2 h in
serum-free medium containing ﬂuorescence-labeled CPP or unconjugated 5-
carboxyﬂuorescein (Fluka) as a control at a concentration of 40 mM. A total
of 4 mM stock solutions of the CPP or of unconjugated carboxyﬂuorescein
were prepared in DMSO to increase the solubility and subsequently diluted
(1:100) with serum-free medium to a ﬁnal concentration of 40 mM. This
concentration was chosen in agreement with previous studies (19,20), as the
uptake mechanism of hCT-derived peptides may involve enrichment (41)
and self-assembly (42) of peptide in the membrane interface. The concen-
tration of DMSO was 1%. Simultaneously, nuclei were stained with 1 mg/ml
Hoechst 33342 (Molecular Probes, Leiden, The Netherlands) for 30 min.
Subsequently, cells were rinsed three times with Hanks’ balanced salt solu-
tion buffer (HBSS) and overlaid with HBSS buffer for observation using
CLSM. To avoid misinterpretation due to unspeciﬁcally bound extracellular
ﬂuorescence, one-half of the volume was replaced with an aqueous 0.4%
Trypan blue solution to quench extracellular ﬂuorescence (43–45). Cells
were then scanned using a Zeiss (Jena, Germany) CLSM 410 inverted
microscope. Image processing was performed using Imaris (Bitplane,
Zurich, Switzerland).
Fluorescence-activated cell
sorting—quantiﬁcation of internalized CPP
To quantify internalized ﬂuorescence-labeled CPP, we performed a ﬂuores-
cence-activated cell sorting analysis (FACS). Again, exponentially growing
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HeLa cells were seeded onto 24 well plates at a density of 35,000 cells/cm2
and were used 1 day after seeding. For uptake experiments, cells were
incubated for 2 h in serum-free medium containing ﬂuorescence-labeled
CPPs or unconjugated 5-carboxyﬂuorescein as a control at a concentration
of 40 mM. A total of 40 mM solutions of the CPPs or of unconjugated dye
was prepared analogously to the procedure used in the CLSM. After in-
cubation, all cells were extensively washed with PBS buffer, and cells
were treated with trypsin for 7 min to detach cells from the surface and to
digest membrane-bound peptide as adopted from the literature (13,46) and
washed once more with PBS before measurement. After addition of Trypan
blue as a quencher for extracellularly bound ﬂuorescence (47,48), FACSwas
performed on a FacScan (BectonDickinson, Franklin Lakes, NJ) within 1 h
after trypsinization. A total of 8000 gated cells per sample were analyzed
using Cytomation Summit software (Cytomation, Fort Collins, CO). The
5-carboxyﬂuorescein control value was subtracted, and results were nor-
malized to the unmodiﬁed hCT(9-32). Statistical comparisons for signiﬁ-
cance were made with Student’s t-test; p# 0:02 was considered statistically
signiﬁcant. All experiments were performed in triplicate.
To check for cell proliferation and viability of HeLa cells after 1 h
of incubation with the so-far not tested CPP A23-hCT(9-32) and W30-
hCT(9-32), we measured the overall activity of mitochondrial dehydroge-
nase (MTT assay) according to the instructions of ATCC (ATCC, MTT Cell
Proliferation Assay Instructions) (49). Brieﬂy, HeLa cells were incubated in
96 well plates (Nunc, Roskilde, Denmark) to 70–80% conﬂuency and then
incubated as described above. As controls we used untreated cells and cells
treated with methanol for 7 min, respectively. After discarding the CPP
solutions, MTT (Sigma, St. Louis, MO) was added for 4 h at 37C. After
removing the MTT solution, the purple precipitate was dissolved for 12 h by
addition of detergent (81 ml isopropanol, 15 ml SDS 20%, 4 ml 1 M HCl).
Overall activity of MTT in each well was measured spectrophotometrically




To test the propensity of hCT to interact with cell mem-
branes, partition coefﬁcients were determined in a liposome-
buffer equilibrium system (25). In contrast to partitioning
studies in isotropic media, e.g., water/octanol, anisotropic
media like liposomes also include ionic interactions and,
therefore, represent a more realistic model. All LUV lipo-
somes prepared displayed unimodal size distributions with
mean diameters of 103.4 6 1.9 nm for POPC. A large lipid/
peptide molar ratio (;200) was chosen to establish a bio-
logically relevant lipid/peptide ratio and to exclude forma-
tion of speciﬁc lipid-peptide aggregates.
Since our NMR studies revealed that at least some of the
peptides (e.g., A23) form aggregates at neutral pH, a pH of
3.5 was chosen to avoid problems associated with differen-
tial aggregation. The apparent partition coefﬁcients D at that
pH were determined after 7 h. Fig. 1 demonstrates the re-
sulting partition coefﬁcients of various hCT-derived CPPs
in neutral POPC LUVs. For hCT(9-32) a D of 66 was de-
termined; it increased by a factor of 2 when replacing Gly2
or Gly30 by Trp. Among all amino acids, Trp is known to
partition most into the water-membrane interface (50). Also
the replacement of the helix-breaking Pro23 by Ala, bridging
the two short a-helical segments, caused a 1.7-fold increase
inD. The hCT(9-32) derivative with a randomized amino acid
sequence showed a largely reduced D value as compared
to hCT(9-32), indicating that not only the amino acid com-
position but also the secondary structure and possibly the
amphipathicity played a signiﬁcant role for the afﬁnity to-
ward membranes.
Peptide effects on bilayer integrity: calcein
leakage experiments
An advantage of hCT-derived CPPs is their low toxicity:
hCT is a human hormone and an approved drug for the
treatment of postmenopausal osteoporosis (18). Furthermore,
Tre´hin et al. (20), using several cell lines, demonstrated
the absence of cytotoxic effects of hCT(9-32), even when
incubated for periods as long as 24 h. To investigate whether
the amino acid substitutions in A23-hCT(9-32) and W30-
hCT(9-32) increased their potential to affect the integrity of
phospholipid membranes, we performed a dye leakage assay
with calcein-loaded POPC LUVs. As shown in Fig. 2 we
compared membrane-permeabilizing effects at increasing
concentrations of the hCT-derived CPPs and melittin as
control in a 200 mM suspension of neutral POPC LUVs at
pH 7.4. Melittin is a basic, amphipathic 26-amino acid pep-
tide for which pore formation in lipid bilayers has been pre-
viously demonstrated to lead to complete calcein leakage
at peptide concentrations as low as 1 mM (51). In contrast,
hCT caused a leakage of only ;8% at a peptide concentra-
tion of 40 mM, which corresponds to a peptide/lipid ratio of
0.2. None of its derivatives exhibited any signiﬁcant leakage.
At the highest concentration of 200 mM, corresponding to
a peptide/lipid ratio of 1.0, hCT caused a leakage of ;40%.
The values for A23-hCT(9-32) and W30-hCT(9-32) were
markedly lower, and hCT(9-32) caused a leakage of ;10%
only.
FIGURE 1 Apparent liposome-buffer partitioning coefﬁcients between
extruded POPC LUVs and acetic acid/acetate buffer, pH ¼ 3.5, at a total
lipid concentration of 4 mM and a peptide concentration of 20 mM. Dialysis
was performed for 7 h at 37C. Results are represented as mean 6 SD of
three independent experiments.
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Structural data from NMR experiments
200 ms NOESY data of hCT(9-32) in pure aqueous solution
at pH 4.1 indicates that the peptide is unstructured in
solution. The NOESY spectra are devoid of medium range
contacts and only display intraresidual and sequential
nuclear Overhauser effects (NOEs). This observation is sup-
ported by scalar coupling constants close to rotationally aver-
aged values of ;7 Hz.
We also recorded a 120 ms NOESY on hCT(9-32) in the
presence of DPC micelles. Continuous stretches of sequen-
tial NOEs of amide protons (HN(i),HN(i1 1)) were observed
between Thr10–Ans17 and Gln24–Val29. In addition, a few
Ha,HN (i,i 1 2) and Ha,Hb(i,i 1 3) restraints were also ob-
served in these stretches. Structure calculations within the
program DYANA conﬁrmed helical folds in these segments.
However, the polypeptide conformation was not sufﬁciently
well deﬁned to assign the conformation to a speciﬁc helix
type, and the data clearly indicated that residual ﬂexibil-
ity was contained in the structures (e.g., scalar couplings
3J(HN,Ha) adopted values between 6 and 7 Hz). As derived
from the structure calculations, hCT(9-32) forms two
amphipathic helices connected via a ﬂexible linker, which
is terminated by Pro23.
We used the micelle-integrating spin labels 5- and 16-
doxylstearate to probe the orientation of the peptide on the
micelle. Whereas the former spin label probes vicinity to
phospholipid headgroups, the latter should affect protons
more deeply inserted into the micelles. We also added Mn21
to the micellar solution, a spin label that mostly affects
solvent-exposed protons. The relative signal attenuation due
to the presence of 5-doxyl stearate was plotted against the
sequence of each of the three peptides hCT(9-32), A23-
hCT(9-32), and W30-hCT(9-32). Signal attenuations for all
three peptides largely followed periodic patterns. Interest-
ingly, the amount of signal reductions generally followed the
order of hCT(9-32) , A23-hCT(9-32) , W30-hCT(9-32),
indicating that the micellar association of the Trp30 ana-
log was tighter than for the other two peptides. Moreover,
introduction of Trp at position 30 induced membrane asso-
ciation of the C-terminal tetrapeptide. Helical periodicity
was most clearly observed for A23-hCT(9-32). Prominent
signal reductions were mainly observed for the aromatic
amino acids Tyr12, Phe16, 19 and 22 as well as for His20, and
for Ala23 and Gly28. Our observations are fully compatible
with thermodynamic data of partitioning whole amino acids
into water-membrane interfaces as measured by White and
Wimley (50). We noticed that only weak signal reductions
were observed in the C-terminal half of hCT(9-32). To in-
vestigate whether the C-terminus integrated into the micelle
interior or was freely diffusing in solution, we conducted
experiments with the spin label Mn21. As a result we ob-
served signiﬁcant signal reductions for the C-terminal seg-
ment of hCT(9-32) (see Fig. 3 D), proving that this part
protruded into the aqueous phase. However, we also ob-
served signal reductions in the region around residue 15
(data not shown), indicating that Mn21 also coordinated to
the side-chain carboxy group of Asp15. The replacement of
Pro23 by Ala resulted in the extension of the amphipathic
helix, but whether this structural effect or the more favorable
partitioning properties of Ala when compared to Pro led to
higher uptake is presently unclear. Nevertheless, Trp30 intro-
duced a new membrane anchor in the C-terminal tetrapeptide
domain, resulting in stronger and more homogenous signal
reductions along the sequence. As derived from these spin
label studies, the membrane-binding afﬁnities followed the
order of hCT(9-32) , A23-hCT(9-32) , W30-hCT(9-32).
This result is most likely due to the extent to which the
C-terminal part of the peptides associated with the micelle.
Patterns for signal reductions due to the spin label 16-
doxylstearate were similar in their trend but less pronounced,
excluding that the peptides more deeply penetrate the micelle
interior.
Confocal laser scanning microscopy: uptake
studies in living cells
Recently, an intense debate occurred in the literature whether
artifacts in the mechanistic interpretation of CPP studies were
caused through cell ﬁxation. Even mild ﬁxation protocols
have been described to give rise to misleading interpretations
about peptide internalization. Therefore, throughout, we
conducted our cellular uptake study in living, nonﬁxed HeLa
cells. In addition, we were aware that routine washings with
buffer did not reliably remove all membrane-bound CPP as
already found in previous studies (13). For both CLSM and
FACS we quenched extracellular ﬂuorescence using Trypan
blue. Cells were exposed to either one of the three CPP or the
FIGURE 2 Percentage leakage of the LUV-entrapped ﬂuorescent dye
calcein as a function of peptide concentration. Peptide solutions up to a ﬁnal
concentration of 200 mM were added to a 400 mM POPC LUV solution in
PBS buffer, pH 7.4. From the increase of calcein ﬂuorescence, the peptide-
induced leakage in percentage was calculated for melittin (n), hCT (s),
hCT(9-32) (d), A23-hCT(9-32) (n), and W30-hCT(9-32) (:). Data were
recorded after 60 min of incubation at ambient temperature (;22C) and are
represented as mean 6 SD (n ¼ 3).
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unconjugated dye. After incubation at 37C for 2 h, cells
showed cellular uptake of all investigated peptides. Cell
nuclei were stained with Hoechst 33342. hCT(9-32) (Fig. 4
A) and W30-hCT(9-32) (Fig. 4 B) exhibited punctuated
ﬂuorescence patterns indicating that the translocated ﬂuo-
rescence was localized in discrete vesicular compartments in
the cytoplasm, suggestive of an endocytic pathway of inter-
nalization.
The cytosolic ﬂuorescence of W30-hCT(9-32) was higher
as compared to the unmodiﬁed hCT(9-32), indicating a more
efﬁcient uptake. The coarse ﬂuorescence pattern for A23-
hCT(9-32) (Fig. 4 C) suggests that, owing to its limited
solubility in serum-free medium, the peptide may have ag-
gregated in larger clusters on the cell membrane, which cannot
be completely quenched by Trypan blue. No intracellular
ﬂuorescence was observed in control cells incubated with the
ﬂuorescence marker 5-carboxyﬂuorescein alone (Fig. 4 D).
Quantitative assessment of peptide
internalization by FACS analysis
In addition to the general trends in translocation as observed
by CLSM, cellular uptake of the CPPs was also monitored
through FACS analysis. HeLa cells were incubated for 2 h
with either the respective CPP or 5-carboxyﬂuorescein as
control at concentrations of 40 mM. The relative median
FIGURE 3 Relative signal intensities in 1H-TOCSY spectra of hCT-
derived peptides in DPC micelles in presence of the spin label 5-doxylstearic
acid with respect to a reference spectrum without spin label. 2 mM solutions
of hCT(9-32) (A), A23-hCT(9-32) (B), and W30- hCT(9-32) (C) were
measured in 300 mM d38-DPC micelles at pH 5.6. The inset in A depicts the
reduction for hCT(9-32) in the presence of the spin label manganese chloride
with respect to a reference spectrum without spin label (D).
FIGURE 4 Confocal microscopy of translocation of hCT(9-32) and its
modiﬁcations in HeLa cells. HeLa cells were incubated for 2 h with 40 mM
peptide solution in serum-free medium of (A) hCT(9-32), (B) W30-hCT
(9-32), (C) A23-hCT(9-32), or (D) 5-carboxyﬂuorescein. Cell nuclei (in blue)
were stained for 30 min with Hoechst 33342 at a concentration of 1 mg/ml.
For extracellular ﬂuorescence quenching, CLSM pictures were taken after
addition of Trypan blue.
FIGURE 5 Quantiﬁcation of cellular internalization of hCT(9-32) and its
modiﬁcations in HeLa cells. HeLa cells were incubated with 40 mM peptide
solutions in serum-free medium for 2 h. FACS analysis was performed after
the addition of Trypan blue to quench extracellular ﬂuorescence. The in-
ternalization of the unmodiﬁed hCT(9-32) was set to 100%, the modi-
ﬁcations’ internalization efﬁciency are expressed as relative percentages.
The results are represented as mean 6 SD (n ¼ 3). Asterisk indicates a
statistically signiﬁcant difference (p , 0.02).
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ﬂuorescence of the cells after internalization is demonstrated
in Fig. 5. Again, Trypan blue was added as a quencher for
extracellularly bound ﬂuorescence. For A23-hCT(9-32) a
more extensive membrane binding was observed as com-
pared to the other two CPP as shown by a more pronounced
reduction in ﬂuorescence after incubation with the quencher
(data not shown). The relative median ﬂuorescence of HeLa
cells after uptake of W30-hCT(9-32) was ;1.4 times higher
(p, 0.02) than that of unmodiﬁed hCT(9-32). However, we
attribute the increase in ﬂuorescence upon A23-hCT(9-32)
partially to a contribution of incompletely quenchedmembrane-
bound ﬂuorescence. FACS and CLSM data were in good
agreement.
Cellular viability of HeLa cells after incubation with the
investigated peptides was monitored by an MTT assay. None
of the investigated peptides exerted a relevant impact on
cellular viability at concentrations ranging from 5 mM to 100
mM (data not shown).
DISCUSSION
The objective of this study was to understand the molecular
mechanism of hCT-derived cell-penetrating peptides as re-
lated to their association with membrane lipids and the trans-
location of the plasma membrane. To establish the role of
individual residues we investigated hCT(9-32) (19,20) and
two mutants thereof. Exchange of residues was performed
to enhance the peptides’ afﬁnity toward membrane lipids to
promote their cellular uptake. For this aim we utilized var-
ious experimental techniques from partitioning and leakage
experiments to high-resolution NMR spectroscopy to probe
peptide-lipid interactions. Biological membranes were mim-
icked by phospholipid liposomes for partitioning studies and
micelles for NMR analysis, respectively. Moreover, we
studied the peptides’ uptake in HeLa cells.
The mode of interaction of CPPs with the lipid membrane
has been vividly discussed. For reviews on this topic see
Lundberg et al. (52) and Magzoub et al. (69). To summarize,
ﬁve different models have been developed: In the case of the
inverted micelle model, CPPs associate with the bilayer
surface, mainly through electrostatic interactions (53) (Fig.
6 A), resulting in containment of the cargo in an inverted
micelle and leakage of its contents into the cytosole. In the
endocytic mechanism, invaginations in the membrane are
formed (Fig. 6 B) which later on evolve into vesicles that
separate into the cytosole. In the barrel-stave model (Fig. 6
C), rearrangements of lipid-associated peptides lead to pore
formation. Pores are created by circular assembly of
amphipathic peptides in transmembrane fashion in such a
way that their hydrophobic domains point to the lipid chains
of the membrane and the hydrophilic side chains to the
interior of the pore (56). In contrast, in the toroidal model
(57) pores are also formed, but headgroups form contacts to
transmembrane-inserted peptides throughout (see Fig. 6 D).
FIGURE 6 Scheme presenting the peptide-phospholipid arrangements in the inverted micelle (A), the initial state of the endocytic process (B), the barrel-
stave (C), toroidal pore (D), and the carpet mechanism (E). The membrane curvature induced by decreased (F, middle) or increased (F, bottom) headgroup-
headgroup distances are compared to a planar arrangement (F, top). Note that for clarity, only the outer leaﬂet is depicted for F.
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The carpet model (Fig. 6 E), on the other hand, which has
been previously suggested for the cellular translocation of
antimicrobial peptides, assumes an initial association of the
peptides with the surface of the membrane. Interactions with
basic residues then result in the reorganization of the lipids
and cause disruption of lipid packing (54,55). It is believed
that the mode of action for CPPs in general may follow dif-
ferent mechanisms.
Which mechanism would apply to a particular CPP will
depend on molecular features. In all models described above,
an initial association of the peptide with the surface of the
bilayer constitutes the ﬁrst step. Although this step is gen-
erally assumed to be governed by electrostatic interactions
with negatively charged membrane lipids, hydrophobic
partitioning cannot be excluded. The thermodynamics of
peptide-lipid interactions has been recently reviewed, and the
interested reader is referred to the excellent review by Seelig
(58). To which extent electrostatic interactions dominate the
ﬁrst step depends on the presence of basic and acidic amino
acids, pH, and salt concentration. Since electrostatic inter-
actions are long range, intrinsic structuring of the peptide is
less important for electrostatic association with the mem-
brane as compared to a situation where hydrophobic inter-
actions would dominate. In fact, many membrane-active
peptides are unstructured in solution but readily fold in
vicinity to the membrane by a coupled partitioning-folding
mechanism (59).
Whereas the ﬁrst step is similar in the three models
described above, the following events are different. In the
inverted micelle/endocytic models, the peptide remains sur-
face bound throughout the complete translocation process
and never penetrates deeply into the hydrophobic interior. In
contrast, in the barrel-stave or toroidal pore models the pep-
tide inserts into the membrane in a transmembrane fashion.
Whereas no major membrane reorganization occurs in the
barrel-stave model, the toroidal pore model implies a re-
arrangement of phospholipid headgroups such that they in-
teract with the hydrophobic side of the peptide and thereby
become transferred into the interior of the membrane.
Clearly, pore formation requires an additional interaction in-
terface in the peptide for homo-oligomerization of the CPPs
to assemble to the barrel. It is presently not clear which mo-
lecular features favor one mechanism over the other. How-
ever, it can be expected that balancing and positioning of
hydrophobic and hydrophilic residues inﬂuence the mech-
anism. Both properties will have an inﬂuence on membrane
binding and membrane insertion.
In the barrel-stave model, interactions with the phospho-
lipid headgroups are made by both C- and N-terminal
residues. In particular Tyr and Trp residues possess a high
tendency to partition into the interface. In the transmembrane
segments of helical peptides that favor the barrel-stave mech-
anism, hydrophobic residues need to be directed toward the
outside of the barrel, whereas the inside of the barrel is likely
to accommodate hydrophilic residues. Otherwise no pores
but helical bundles would be formed. Therefore, the suc-
cessful assembly of such barrels depends critically on how
likely oligomerization is and is also strongly favored in the
absence of residues like Tyr and Trp in the central segment of
the peptide.
In contrast, in the toroidal pore model, reorganization of
the phospholipids occurs such that interactions with phos-
pholipid headgroups take place throughout the helix. There-
fore, we expect this mode to be favored when aromatic
residues are placed in the central segment and when oligo-
merization is favored additionally.
The requirements for an inverted-micelle/endocytic type
mechanism seem to be different in that a few residues that
anchor the peptide on the membrane are sufﬁcient, but their
position is probably not critical. In contrast to the toroidal
pore mechanism, there is no need for oligomerization. More-
over, the membrane surface in the inverted-micelle mecha-
nism is concave, whereas it is convex in the toroidal pore
mechanism (60). A concave membrane surface is formed
when the headgroups move together more closely, whereas
the convex surface is characterized by increased distances
between them (see Fig. 6 F). It has been argued that the
distance between the headgroups is promoted by electrostatic
repulsion. Thus cationic residues may act by partially com-
pensating the negative charges, thereby allowing the head-
groups to move more closely together (61). In contrast,
intercalation of side chains into the hydrophobic interior may
increase distances between headgroups, thereby promoting
concave surfaces.
The topology of peptide-lipid aggregates in the carpet
model is much less well deﬁned and hence it is more difﬁcult
to predict which molecular properties would favor such a
mechanism.
The overall hydrophobicity of the peptides and their
afﬁnity toward membranes was probed by liposome-buffer
partitioning experiments and demonstrated marked to high
afﬁnities of hCT-derived peptides to neutral POPC bilayers.
In particular, we observed close agreement of partitioning
with published thermodynamic data. Wimley and White
have experimentally determined free energies of transferring
whole amino acids from bulk solution into the membrane-
water interface or into the hydrophobic interior (50). The
corresponding values for Gly and Trp residues are 0.01 and
1.85 kcal/mol for the transfer into the interface (DGwif)
and 1.15 and –2.09 kcal/mol into the hydrophobic interior
(DGoct), respectively. Accordingly, we observed a substantial
increase in afﬁnity to POPC LUVs in our partitioning ex-
periments when Gly was replaced by Trp. A similar increase
in afﬁnity was observed by replacing Pro23 (DGwif ¼ 0.45
kcal/mol, DGoct ¼ 0.14 kcal/mol) in the middle of the
peptide sequence by an Ala (DGwif¼ 0.17 kcal/mol, DGoct¼
0.50 kcal/mol).
After initial membrane association of the peptides, which
is most probably governed by the net charge of the peptide in
vicinity to the membrane (note that this may substantially
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differ from that in bulk solution), any further steps, in par-
ticular those requiring interactions with the hydrophobic side
chains, will certainly depend on the structure of the peptides
when bound to the membrane. This view is supported by our
observation that the partition coefﬁcient of the random
sequence is much lower when compared to the values from
the hCT-derived peptides demonstrating that, in addition
to amino acid sequence, secondary structure also plays a sig-
niﬁcant role for their afﬁnity to phospholipid membranes.
We would like to add that, due to the coupled partitioning-
folding mechanism, residues such as Trp are likely to in-
crease membrane-binding afﬁnity and exert a stabilizing
effect on secondary structure.
Previously, structures and positioning of the CPPs
penetratin and transportan have been determined by NMR
in different membrane model systems. Penetratin was found
to adopt an a-helical conformation in SDS micelles as well
as in partially negatively charged bicelles (62–64), with the
helix being parallel aligned to the bicelle surface. Berlose
et al. similarly proposed a parallel adoption to the surface
also for SDS micelles (62), whereas others could not un-
ambiguously position the peptide on SDS micelles (63).
Transportan, a chimeric peptide constructed from galanin
and mastoparan, was found to be a-helical in the mastoparan
part and mainly unstructured in the galanin part in SDS.
Based on spin label experiments, the mastoparan segment
inserts into the micelle, whereas the galanin part resides in
the interface (65). In a recent study in neutral bicelles,
the mastoparan part was observed to adopt a well-deﬁned
a-helix, and the galanin part displayed a weaker tendency to
form an a-helix. The whole peptide was found to be oriented
in parallel with the membrane-water interface (66). Interest-
ingly, like the hCT-derived CPPs investigated in this study,
these two peptides were also mainly located at the interface,
indicating that an initial strong interaction of the CPPs with
membranes is an important prerequisite for translocation.
Structures of the hCT(9-32) peptides in their micelle-
bound form are predominantly helical, in contrast to the
unligated peptides in solution that are unstructured. hCT
(9-32) is characterized by two short helical stretches, extend-
ing from Thr10 to Asn17 and from Gln24 to Val29, which, how-
ever, possess some additional ﬂexibility. To gain further
insight into the importance of secondary structure for trans-
location, we replaced Pro23, the strongest a-helix breaker, by
Ala, which is known to be one of the most efﬁcient a-helix
promoters (67). In fact, A23-hCT(9-32) adopted a continuous
a-helical structure from residue 12 to 26. Our spin label
studies with 5-doxylstearate demonstrated that the more
hydrophobic residues Tyr12, Phe16, 18 and 22, and His20,
Ala23, and Gly28 are integrated into the micelle, leaving the
hydrophilic residues Gln14 and 24, Asp15, Asn17, and Lys18
exposed to the aqueous phase. Thereby A23-hCT(9-32) forms
a continuous amphipathic helix. The spin label data for
A23-hCT(9-32) nicely reﬂect periodicity of the helix, also
indicating that the peptide was well anchored on the micelle
surface. The prolonged helix should result in a larger
membrane-binding interface, and this expectation was well
met by both the increased partition coefﬁcient as well as the
increased propensity for aggregation of ﬂuorescein-labeled
A23-hCT(9-32). Unfortunately, the increase in ﬂuorescence
intensity as detected by FACS analysis may also be due to
formation of aggregates on the cells surface, which would
present a drawback for the applicability of A23-hCT(9-32)
as a CPP.
In addition, we introduced a Trp residue into the
C-terminal segment by replacing Gly30, which in wild-type
hCT(9-32) was not associated to the membrane. The Gly30Trp
exchange resulted in stable anchoring of the C-terminal
segment on the phospholipid micelles, clearly evident from
the large attenuations observed in the spin label experiments.
The additional membrane-anchor resulted in a twofold in-
crease of the partition coefﬁcient. Interestingly, tighter bind-
ing to model membranes in vitro was accompanied by higher
uptake into HeLa cells in vitro. The regular, punctuated
ﬂuorescence pattern indicated vesicular localization of W30-
hCT(9-32) and therefore an endocytic pathway of inter-
nalization. The brighter ﬂuorescence of W30-hCT(9-32) as
compared to hCT(9-32) observed in the CLSM was con-
ﬁrmed by signiﬁcantly higher ﬂuorescence detected by
FACS analysis. Together with the apparent lack of toxicity,
this makes W30-hCT(9-32) a promising CPP candidate for
further exploration.
In accordance with our observation of a decreased afﬁnity
toward liposomes, a previous study showed that hCT(ran-
dom) was not taken up into MDCK cells, whereas hCT(9-32)
was efﬁciently internalized (19).
Any mechanism for translocation resulting in membrane
permeabilization would be unacceptable from a pharmaceu-
tical point of view when associated with increased cyto-
toxicity. This study was also performed to reveal whether the
CPPs confer cytotoxic effects that would prevent their use in
drug delivery. Dye leakage experiments were performed to
assure that the sequence modiﬁcations do not increase the
potential for membrane permeabilization. In fact, no leakage
was found to occur for any of the modiﬁcations up to a
concentration of 50 mM, which was above the concentration
used in cell culture experiments (40 mM). At concentrations
higher than 50 mM the modiﬁed peptides, A23-hCT(9-32)
and W30-hCT(9-32), display a slightly increased propensity
for leakage relative to hCT(9-32), but remain signiﬁcantly
below the values measured for full-length hCT. Accordingly,
in vitro experiments with 5 mM–100 mM peptide solution
revealed no effects on cellular viability on HeLa cells, neither
for hCT(9-32), nor the modiﬁed peptides A23-hCT(9-32)
and W30-hCT(9-32). This is in agreement with a previous
study where 40 mM hCT(9-32) on MDCK monolayers
revealed no signiﬁcant toxicity after 120 min (19). In ad-
dition ﬂuorescein-labeled hCT(9-32) was tested on three
different cell lines, and no indications for toxicity were ob-
served for any of the cell lines even at 100 mM, the highest
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tested concentration (20). As shown by Christiaens et al. (17),
peptides are generally more likely to induce leakage of dye-
loaded LUVs than exhibit toxic effects on cell cultures.
Nevertheless, in black lipid membranes composed of POPC/
DOPG (85:15), untruncated hCT was shown to induce
a slight formation of voltage-dependent channels that allow
permeation of calcium ions (68) after 200 min of incubation.
At the conditions of our study, pore formation as a possible
mechanism of translocation can be ruled out. Hence we
exclude the cellular translocation of the investigated CPP to
follow the barrel-stave model.
Instead, both the spectroscopic part of our work as well as
the in vitro studies indicate an endocytic mechanism. The
liposome-leakage study disfavors any model that requires
permeabilization such as the barrel-stave, the toroidal pore
or, to a lesser extent, the carpet model. The structures of
hCT(9-32) displayed two rather short helical segments
disrupted by Pro23. Replacement of the latter by Ala resulted
in a continuous helix. However, spin label data indicated that
membrane binding in the central segment was not particu-
larly pronounced as supported by the absence of residues like
Trp or Tyr in that segment which would strongly partition
into the interface. Rather, the amino acid composition of the
peptides implies a moderate association of the peptides
with the membrane, and the spin label data indicate that
the peptides remain surface associated. Moreover, we see no
indication for oligomerization of the peptides in or on the
membrane. The initial steps of the inverted micelle model
require invaginations of the membrane and are highly similar
to early events in endocytosis. Indeed, the punctuated ﬂuores-
cence pattern indicating vesicular localization of ﬂuorescein-
labeledW30-hCT(9-32) suggests that endocytosis takes place,
certainly to a considerable extent.
This work was supported by the Commission of the European Union (EU
project on Quality of Life and Management of Living Resources, project
No. QLK2-CT-2001-01451).
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